# AstraZeneca Pharmaceuticals, LP – FDA Inspection, Mar 29, 2016

Source: https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/65a34f00-14ed-4660-a63b-a2f0505b795a
Source feed: FDA_Inspections

> FDA inspection 963627 of AstraZeneca Pharmaceuticals, LP, March 29, 2016. Classification: Official Action Indicated (OAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 963627
- Company Name: AstraZeneca Pharmaceuticals, LP
- Inspection Date: 2016-03-29
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1312298 - 2026-04-03
- FDA Inspection 1047488 - 2018-03-05
- [FDA Inspection 998797 - 2017-01-30](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/ee0ecf07-7650-4fab-bc7f-784e9249d085)
- FDA Inspection 954660 - 2015-12-18

Company: https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/24c4d7fa-217f-4286-8074-011be79e658f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
